Literature DB >> 16706822

Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.

Steven Woon Choy Tsang1, Wing Fung Ng, Brian Ping Ying Wu, David Alan Chow, Eric Ting Ho Li, Tak Cheung Wong.   

Abstract

BACKGROUND AND AIM: Non-alcoholic steatohepatitis (NASH) is increasingly recognized as an important cause of chronic liver disease. However, data on Asians with NASH is lacking in the literature. The aim of the present study was to describe the clinical, biochemical and histological characteristics of NASH in Asians and to determine the predictors for septal fibrosis.
METHOD: Sixty consecutive patients aged over 18 years with elevated serum alanine transferase, sonographic evidence of steatosis, and consent for liver biopsy were included. Patients with chronic hepatitis B or C, alcoholic, autoimmune, genetic, or drug-induced liver disease were excluded. Clinical, biochemical and histological variables were tested for association with septal liver fibrosis (F2/3).
RESULTS: Median age of the cohort was 45.5 years (range 21-75 years) and 63% were male. Ninety percent of patients were obese (body mass index [BMI]>or= 25), 70% had hypertriglyceridemia, 68% had hypercholesterolemia, 58% had metabolic syndrome, 53% had hypertension, 47% had diabetes mellitus (DM), and 18% had obstructive sleep apnea. Sixty-eight percent had gamma-glutamyl transferase (GGT) >or= 2 x upper limit of normal (ULN), 55% had alanine aminotransferase (ALT) >or= 2 x ULN, and 23% had aspartate aminotransferase (AST) >or= 2 x ULN. Of the 40 non-diabetic patients undergoing oral glucose tolerance testing, 45% had normal tests, 30% had impaired glucose tolerance, 23% DM, and 2% impaired fasting glucose. Eighteen patients (30%) had septal fibrosis (F2/3), but none had cirrhosis. Necroinflammatory grade >or= 2 (odds ratio [OR] 13), AST >or= 2 x ULN (OR 5.3) and DM (OR 5) were significantly and independently correlated with septal fibrosis.
CONCLUSION: Septal fibrosis is common in Asians with NASH. Necroinflammatory grade >or= 2, AST >or= 2 x ULN and DM are independent predictors for septal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706822     DOI: 10.1111/j.1440-1746.2005.04146.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.

Authors:  Susanne Bonekamp; An Tang; Arian Mashhood; Tanya Wolfson; Christopher Changchien; Michael S Middleton; Lisa Clark; Anthony Gamst; Rohit Loomba; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2014-06       Impact factor: 4.813

2.  Protective effect of probucol on liver injury induced by carbon tetrachloride in rats.

Authors:  Yu-Tao Zhan; Jing Weng; Li Li; Qing Xu; Xin Song; Xiao-Xia Guo
Journal:  Hepatol Int       Date:  2011-02-10       Impact factor: 6.047

Review 3.  Can NASH be diagnosed, graded, and staged noninvasively?

Authors:  Garfield A Grandison; Paul Angulo
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

4.  Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.

Authors:  Yusuf Yılmaz; Haluk Tarık Kanı; Coşkun Özer Demirtaş; Eda Kaya; Aybüke Fatma Sapmaz; Lubna Qutranji; Tasnim Alkayyali; Kerim Deniz Batun; Mahmut Batman; Berk Toy; Aslı Çiftaslan
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

Review 5.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

6.  Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors.

Authors:  Kaumudee Pattnaik; Pallavi Bhuyan; Ayaskant Singh; Shivaram P Singh; Preetam Nath; Sanjib Kar; Bijay Misra; Jayashree Rath
Journal:  J Clin Exp Hepatol       Date:  2018-01-08

Review 7.  The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases.

Authors:  Kamila Wójcik-Cichy; Ewa Koślińska-Berkan; Anna Piekarska
Journal:  Clin Exp Hepatol       Date:  2018-01-20

8.  Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Su Jong Yu; Won Kim; Donghee Kim; Jung-Hwan Yoon; Kyoungbun Lee; Jung Ho Kim; Eun Ju Cho; Jeong-Hoon Lee; Hwi Young Kim; Yoon Jun Kim; Chung Yong Kim
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.